Emily English

CIK: 0002019791

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (22.2%)

Position reduction

Option Exercises (M)5 (55.6%)

Derivative conversions

Awards (A)2 (22.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RNAC

Cartesian Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

RNAC
Cartesian Therapeutics, Inc.
Jan 2, 2026
Award(A)
Direct
24K shares-
RNAC
Cartesian Therapeutics, Inc.
Dec 30, 2025
Exercise(M)
Direct
7.5K shares at avg. $3.30$25K
RNAC
Cartesian Therapeutics, Inc.
Nov 28, 2025
Exercise(M)
Direct
7.5K shares at avg. $3.30$25K
RNAC
Cartesian Therapeutics, Inc.
May 12, 2025
Exercise(M)
Direct
7.5K shares at avg. $3.30$25K
RNAC
Cartesian Therapeutics, Inc.
Apr 15, 2025
Exercise(M)
Direct
7.5K shares at avg. $3.30$25K
RNAC
Cartesian Therapeutics, Inc.
Jan 6, 2025
Sale(S)
Direct
906 shares at avg. $16.83$15K
RNAC
Cartesian Therapeutics, Inc.
Jan 3, 2025
Sale(S)
Direct
891 shares at avg. $16.72$15K
RNAC
Cartesian Therapeutics, Inc.
Jan 2, 2025
Award(A)
Direct
16.1K shares-
RNAC
Cartesian Therapeutics, Inc.
Dec 26, 2024
Exercise(M)
Direct
7.7K shares at avg. $3.30$25K

		Type	Shares	Price		Ownership
Jan 2, 2026	RNAC Cartesian Therapeutics, Inc.	Award(A)	24,000	-	$0	Direct
Dec 30, 2025	RNAC Cartesian Therapeutics, Inc.	Exercise(M)	7,500	$3.30	$24,750	Direct
Nov 28, 2025	RNAC Cartesian Therapeutics, Inc.	Exercise(M)	7,500	$3.30	$24,750	Direct
May 12, 2025	RNAC Cartesian Therapeutics, Inc.	Exercise(M)	7,500	$3.30	$24,750	Direct
Apr 15, 2025	RNAC Cartesian Therapeutics, Inc.	Exercise(M)	7,500	$3.30	$24,750	Direct
Jan 6, 2025	RNAC Cartesian Therapeutics, Inc.	Sale(S)	906	$16.83	$15,250	Direct
Jan 3, 2025	RNAC Cartesian Therapeutics, Inc.	Sale(S)	891	$16.72	$14,899	Direct
Jan 2, 2025	RNAC Cartesian Therapeutics, Inc.	Award(A)	16,100	-	$0	Direct
Dec 26, 2024	RNAC Cartesian Therapeutics, Inc.	Exercise(M)	7,650	$3.30	$25,245	Direct

1-9 of 9 transactions

About English Emily

English Emily (SEC CIK 0002019791) files insider reports with the SEC as Chief Operations Officer of Cartesian Therapeutics, Inc. (RNAC).

Signal8 holds 8 ownership filings by English Emily, all Form 4s, filed between Dec 30, 2024 and Jan 6, 2026. Those filings report 9 transactions, from Dec 26, 2024 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on English Emily's filings is in FREDERICK, MD.

Recent filings by English Emily

Jan 2, 2026: Grant or award of RNAC shares (Form 4, code A).
Dec 30, 2025: Option exercise of RNAC shares (Form 4, code M).
Nov 28, 2025: Option exercise of RNAC shares (Form 4, code M).
May 12, 2025: Option exercise of RNAC shares (Form 4, code M).
Apr 15, 2025: Option exercise of RNAC shares (Form 4, code M).

Other insiders filing for Cartesian Therapeutics, Inc. (RNAC)

Hoge Elizabeth, 10% Owner
Kalayoglu Murat, 10% Owner
Singer Michael, Director
Brunn Carsten, President and CEO
Miljkovic Milos, Chief Medical Officer
Davis Blaine, Chief Financial Officer

How to read Form 4 transaction codes